Page 846 - Williams Hematology ( PDFDrive )

820 Part VI: The Erythrocyte Chapter 53: Hemolytic Anemia Resulting from Infections with Microorganisms 821

54. Tham WH, Healer, J Cowman A: Erythrocyte and reticulocyte binding-like proteins of 88. Seder RA, Chang LJ, Enama ME, et al: Protection against malaria by intravenous
Plasmodium falciparum. Trends Parasitol 28:23, 2012. immunization with a nonreplicating sporozoite vaccine. Science 341:1359, 2013.
55. Crosnier C, Bustamante LY, Bartholdson SJ, et al: Basigin is a receptor essential for 88a. Riley EM, Stewart VA. Immune mechanisms in malaria: New insights in vaccine devel-
erythrocyte invasion by Plasmodium falciparum. Nature 480:534, 2011. opment. Nat Med 19:168, 2013.
56. Goldberg D, Cowman A: Moving in and renovating: Exporting proteins from Plas- 89. Aldana L: Bacteriologia de la enfermedad de carrion. Cron Med 46:235, 1929.
modium into host erythrocytes. Nat Rev Microbiol 8:617, 2010. 90. Xu YH, Lu ZY, Ihler GM: Purification of deformin, an extracellular protein synthesized
57. Nakamura K, Hasler T, Morehead K, et al: Plasmodium falciparum-infected erythrocyte by Bartonella bacilliformis which causes deformation of erythrocyte membranes. Bio-
receptor(s) for CD36 and thrombospondin are restricted to knobs on the erythrocyte chim Biophys Acta 1234:173, 1995.
surface. J Histochem Cytochem 40:1419, 1992. 91. Mitchell SJ, Minnick MF: Characterization of a two-gene locus from Bartonella bacilli-
58. Newbold C, Warn P, Black G, et al: Receptor-specific adhesion and clinical disease in formis associated with the ability to invade human erythrocytes. Infect Immun 63:1552,
Plasmodium falciparum. Am J Trop Med Hyg 57:389, 1997. 1995.
59. Baruch DI, Ma XC, Singh HB, et al: Identification of a region of PfEMP1 that mediates 92. Weinman D: Human Bartonella infection and African sleeping sickness. Bull N Y Acad
adherence of Plasmodium falciparum infected erythrocytes to CD36: Conserved func- Med 22:647, 1946.
tion with variant sequence. Blood 90:3766, 1997. 93. García-Esteban C, Gil H, Rodríguez-Vargas M, et al: Molecular method for Bartonella
60. Sherman IW, Eda S, Winograd E: Cytoadherence and sequestration in Plasmodium fal- species identification in clinical and environmental samples. J Clin Microbiol 46:776,
ciparum: Defining the ties that bind. Microbes Infect 5:897, 2003. 2008.
61. Udomsangpetch R, Taylor BJ, Looareesuwan S, et al: Receptor specificity of clinical 94. Dalton MJ, Robinson LE, Cooper J, et al: Use of Bartonella antigens for serologic diag-
Plasmodium falciparum isolates: Nonadherence to cell-bound E-selectin and vascular nosis of cat-scratch disease at a national referral center. Arch Intern Med 155:1670,
cell adhesion molecule-1. Blood 88:2754, 1996. 1995.
62. McCormick CJ, Craig A, Roberts D, et al: Intercellular adhesion molecule-1 and CD36 95. Eremeeva ME, Gerns HL, Lydy SL, et al: Bacteremia, fever, and splenomegaly caused by
synergize to mediate adherence of Plasmodium falciparum-infected erythrocytes to cul- a newly recognized Bartonella species. N Engl J Med 356:2381, 2007.
tured human microvascular endothelial cells. J Clin Invest 100:2521, 1997. 96. Koehler JE, Sanchez MA, Tye S, et al: Prevalence of Bartonella infection among human
63. Bridges DJ, Bunn J, van Mourik JA, et al: Rapid activation of endothelial cells enables immunodeficiency virus-infected patients with fever. Clin Infect Dis 37:559, 2003.
Plasmodium falciparum adhesion to platelet-decorated von Willebrand factor strings. 97. Reubush TK II, Cassaday PB, Marsh HJ, et al: Human babesiosis on Nantucket Island.
Blood 115:1472, 2010. Ann Intern Med 86:6, 1977.
64. Cockburn IA, MacKinnon MJ, O’Donnell A, et al: A human complement receptor 98. Krause PJ: Babesiosis. Med Clin North Am 86:361, 2002.
1 polymorphism that reduces Plasmodium falciparum rosetting confers protection 99. Krause PJ, McKay K, Gadbaw J, et al: Increasing health burden of human babesiosis in
against severe malaria. Proc Natl Acad Sci U S A 101:272, 2004. endemic sites. Am J Trop Med Hyg 68:431, 2003.
65. Herrera S, Rudin W, Herrera M, et al: A conserved region of the MSP-1 surface protein 100. Herwaldt BL, McGovern PC, Gerwel MP, et al: Endemic babesiosis in another eastern
of Plasmodium falciparum contains a recognition sequence for erythrocyte spectrin. state: New Jersey. Emerg Infect Dis 9:184, 2003.
EMBO J 12:1607, 1993. 101. Jacoby GA, Hunt JV, Kosinski KS, et al: Treatment of transfusion-transmitted babesiosis
66. Lamikanra AA, Brown D, Potocnik A, et al: Malarial anemia: Of mice and men. Blood by exchange transfusion. N Engl J Med 303:1098, 1980.
110:18, 2007. 102. Smith RP, Evans AT, Popovsky M, et al: Transfusion-acquired babesiosis and failure of
67. Mombo LE, Ntoumi F, Bisseye C, et al: Human genetic polymorphisms and asymptom- antibiotic treatment. JAMA 256:2726, 1986.
atic Plasmodium falciparum malaria in Gabonese school-children. Am J Trop Med Hyg 103. Herwaldt BL, Kjemtrup AM, Conrad PA, et al: Transfusion-transmitted babesiosis
68:186, 2003. in Washington State: First reported case caused by a WA1-type parasite. J Infect Dis
68. Clegg JB, Weatherall DJ: Thalassemia and malaria: New insights into an old problem. 175:1259, 1997.
Proc Assoc Am Physicians 111:278, 1999. 104. Nelson R: Blood on demand. Am Herit Invent Technol 19:24, 2004.
69. Zimmerman PA, Patel SS, Maier AG, et al: Erythrocyte polymorphisms and malaria 105. Dobroszycki J, Herwaldt BL, Boctor F, et al: A cluster of transfusion-associated babesi-
parasite invasion in Papua New Guinea. Trends Parasitol 19:250, 2003. osis cases traced to a single asymptomatic donor. JAMA 281:927, 1999.
70. Angus BJ, Chotivanich K, Udomsangpetch R, White NJ: In vivo removal of malaria 106. Kjemtrup AM, Lee B, Fritz CL, et al: Investigation of transfusion transmission of a
parasites from red blood cells without their destruction in acute falciparum malaria. WA1-type babesial parasite to a premature infant in California. Transfusion 42:1482,
Blood 90:2037, 1997. 2002.
71. Jakeman GN, Saul A, Hogarth WL, Collins WE: Anaemia of acute malaria infections 107. Steketee RW, Eckman MR, Burgess EC, et al: Babesiosis in Wisconsin. A new focus of
in non-immune patients primarily results from destruction of uninfected erythrocytes. disease transmission. JAMA 253:2675, 1985.
Parasitology 119(Pt 2):127, 1999. 108. Homer MJ, Aguilar-Delfin I, Telford SR 3rd, et al: Babesiosis. Clin Microbiol Rev 13:451,
72. George JN, Wicker DJ, Fogel BJ, et al: Erythrocytic abnormalities in experimental 2000.
malaria. Proc Soc Exp Biol Med 124:1086, 1967. 109. Cheng D, Yakobi-Shvilli R, Fernandez J: Life-threatening hypotension from babesiosis
73. Overman RR: Reversible cellular permeability alterations in disease. In vivo studies on hemolysis. Am J Emerg Med 20:367, 2002.
sodium, potassium and chloride concentrations in erythrocytes of the malarious mon- 110. Wittner M, Rowin KS, Tanowitz HB, et al: Successful chemotherapy of transfusion
key. Am J Physiol 152:113, 1948. babesiosis. Ann Intern Med 96:601, 1982.
74. Gatidis S, Föller M, Lang F: Hemin-induced suicidal erythrocyte death. Ann Hematol 111. Weiss LM: Babesiosis in humans: A treatment review. Expert Opin Pharmacother
88:721, 2009. 3:1109, 2002.
75. Clark IA, Hunt NH: Evidence for reactive oxygen intermediates causing hemolysis and 112. Clancy MT, OBriain S: Fatal Clostridium welchii septicaemia following acute cholecys-
parasite death in malaria. Infect Immun 39:1, 1983. titis. Br J Surg 62:518, 1975.
76. Stocker R, Cowden WB, Tellan RL, et al: Lipids from Plasmodium vinckei-infected ery- 113. Hamoda H, Chamberlain PF: Clostridium welchii infection following amniocentesis: A
throcytes and their susceptibility to oxidative damage. Lipids 22:51, 1987. case report and review of the literature. Prenat Diagn 22:783, 2002.
77. Yuthavong Y, Limpaiboon T: The relationship of phosphorylation of membrane pro- 114. Simpkins H, Kahlenberg A, Rosenberg A, et al: Structural and compositional changes
teins with the osmotic fragility and filterability of Plasmodium berghei-infected mouse in the red cell membrane during Clostridium welchii infection. Br J Haematol 21:173,
erythrocytes. Biochim Biophys Acta 929:278, 1987. 1971.
78. Balcerzak SP, Arnold JD, Martin DC: Anatomy of red cell damage by Plasmodium falci- 115. Mahn HE, Dantuono LM: Postabortal septicotoxemia due to Clostridium welchii. Am J
parum in man. Blood 40:98, 1972. Obstet Gynecol 70:604, 1955.
79. Jenkins NE, Chakravorty SJ, Urban BC, et al: The effect of Plasmodium falciparum infection 116. Moustoukas NM, Nichols RL, Voros D: Clostridial sepsis: Unusual clinical presenta-
on expression of monocyte surface molecules. Trans R Soc Trop Med Hyg 100:1007, 2006. tions. South Med J 78:440, 1985.
80. Helegbe GK, Goka BQ, Kurtzhals JA, et al: Complement activation in Ghanaian chil- 117. Neter E: Bacterial hemagglutination and hemolysis. Bacteriol Rev 20:166, 1956.
dren with severe Plasmodium falciparum malaria. Malar J 6:165, 2007. 118. Ceppellini R, De Gregorio M: Crisi emolitica in animali batterio-immuni transfusi con
81. Price R, van Vugt M, Phaipun L, et al: Adverse effects in patients with acute falciparum sangue omologo sensibilizzato in vitro mediante l’antigene batterico specifico. Boll Ist
malaria treated with artemisinin derivatives. Am J Trop Med Hyg 60:547, 1999. Sieroter Milan 32:445, 1953.
82. Mouatcho JC, Goldring JP. Malaria rapid diagnostic tests: Challenges and prospects. J 119. Dausset J, Moullec J, Bernard J: Acquired hemolytic anemia with polyagglutinability of
Med Microbiol 62(Pt 10):1491, 2013. red blood cells due to a new factor. Blood 14:1079, 1959.
83. Weiss JB: DNA probes and PCR for diagnosis of parasitic infections. Clin Microbiol Rev 120. Klein PJ, Vierbuchen M, Roth B, et al: Hemolytic anemia in infections caused by
8:113, 1995. neuraminidase-producing bacteria. Verh Dtsch Ges Pathol 67:415, 1983.
84. Mangold KA, Manson RU, Koay ES, et al: Real time PCR for detection and identifica- 121. McGinniss MH, Macher AM, Rook AH, Alter HJ: Red cell autoantibodies in patients
tion of Plasmodium spp. J Clin Microbiol 43: 2435, 2005. with acquired immune deficiency syndrome. Transfusion 26:405, 1986.
85. Campuzano-Zuluaga G, Hanscheid T, Grobusch MP. Automated haematology analysis 122. Zuelzer WW, Stulberg CS, Page RH, et al: The Emily Cooley lecture. Etiology and
to diagnose malaria. Malar J 9:346, 2010. pathogenesis of acquired hemolytic anemia. Transfusion 6:438, 1966.
86. Flannery EL, Chatterjee AK, Winzeler EA. Antimalarial drug discovery—Approaches 123. Walker CL, Applegate JA, Black RE. Haemolytic-uraemic syndrome as a sequela of
and progress towards new medicines. Nat Rev Microbiol 11:849, 2013. diarrhoeal disease. J Health Popul Nutr 30:257, 2012.
87. Beutler E, Duparc S; G6PD Deficiency Working Group: Glucose-6-phosphate dehydro- 124. Dickgiesser A: Campylobacter infection and the hemolytic-uremic syndrome. Immun
genase deficiency and antimalarial drug development. Am J Trop Med Hyg 77:779, 2007. Infekt 11:71, 1983.

Kaushansky_chapter 53_p0815-0822.indd 821 9/17/15 2:56 PM